Vaishali Pharma Boosts Shareholder Value with Stock Split and Bonus Issue

Vaishali Pharma Ltd is executing a stock split and issuing bonus shares to enhance shareholder value. The Mumbai-based company recently expanded its market by obtaining 19 international registrations, expected to boost annual revenues markedly. Its robust portfolio and strategic moves underline its growth and operational success.

Mumbai, India: Vaishali Pharma Ltd, a leading pharmaceutical firm, has announced a strategic move to split its equity shares from a nominal value of INR 10 to five shares of INR 2 each. The board has set October 15, 2024, as the Record Date for this transaction.

In addition to the stock split, the company will issue bonus shares in a 1:1 ratio, providing one new fully paid-up equity share for every existing share. This initiative aims at rewarding shareholders and enhancing liquidity in the market.

Vaishali Pharma recently secured 19 international registrations which are set to contribute an estimated Rs 100 million to its annual revenue. The firm's sales and profit growth in Q1FY25 underline its strong market position and financial health. Chairman Atul Vasani affirmed that these actions reflect the company's commitment to growth and shareholder trust.

(With inputs from agencies.)